UNTERNEHMENSDATEN
Xencor Inc., a biopharmaceutical firm headquartered in Monrovia, California, and established in 1997, operates as a clinical-stage entity. Its central mission involves the discovery and sophisticated engineering of monoclonal antibody and cytokine therapeutics, primarily aimed at treating patients afflicted with cancer and autoimmune disorders. The company is associated with several notable therapies currently in use, such as Sotrovimab, which targets the SARS-CoV-2 virus; Ultomiris, prescribed for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome; and Monjuvi, indicat …
KURSVERLAUF
1T
+0,6 %
1W
-2,3 %
1M
+32,7 %
6M
+51,6 %
YTD
+30,4 %
1J
+121,2 %
2J
-7,8 %
5J
-37,2 %
10J
+5,4 %
FRAG DIE AGENTEN ZU XNCR
Keine Anlageberatung. Für die vollständige Analyse-Übersicht: zur Analyse-Seite →
ANALYSTEN-EINSCHÄTZUNG
KURSZIEL TIEF
27,00 $
KONSENS
27,00 $
MEDIAN
27,00 $
KURSZIEL HOCH
27,00 $
1
STRONG BUY
24
BUY
2
HOLD
1
SELL
0
STRONG SELL
28
GESAMT · Buy
| DATUM | ANALYSTENHAUS | RATING | AKTION |
|---|---|---|---|
| 07.07.2026 | Truist Securities | Buy | maintain |
| 11.05.2026 | JP Morgan | Neutral | maintain |
| 24.03.2026 | JP Morgan | Overweight → Neutral | downgrade |
| 26.02.2026 | Barclays | Overweight | maintain |
| 17.12.2025 | Barclays | Overweight | maintain |
| 06.11.2025 | RBC Capital | Outperform | maintain |
| 06.11.2025 | JP Morgan | Overweight | maintain |
| 06.11.2025 | Cantor Fitzgerald | Overweight | maintain |
KENNZAHLEN
KGV
-8,72
KBV
2,91
EV/EBITDA
-12,47
EIGENKAPITALRENDITE
-25 %
NETTOMARGE
-2.854,7 %
VERSCHULDUNG (D/E)
0,34
DIVIDENDENRENDITE
0 %
STAND
31.03.2026
FREE FLOAT & LIQUIDITÄT
STREUBESITZ
73,4 %
AKTIEN IM STREUBESITZ
54.417.707
Ø TAGESVOLUMEN (30T)
1.074.948
INVESTIERTE FONDS
| FONDS / INSTITUTION | ANTEILE | VERÄNDERUNG | STAND |
|---|---|---|---|
| Essex LLC | 98.661 | +0 | 30.06.2026 |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 70.526 | +2.339 | 30.06.2026 |
| Louisiana State Employees Retirement System | 32.500 | +800 | 30.06.2026 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 28.147 | +9.688 | 30.06.2026 |
| State of Alaska, Department of Revenue | 24.417 | -10.833 | 30.06.2026 |
Keine Anlageberatung. Vergangene Wertentwicklung ist kein Indikator für zukünftige Ergebnisse.